Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.

A. Quattrone, G. Tedeschi, U. Aguglia, F. Scopacasa, GF Direnzo, L. Annunziato

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Acute oral administration of various doses of fenfluramine, a 5‐HT releaser, induced a dose‐related increase of PRL secretion in nine healthy volunteers. Fenfluramine reached the maximum effect on PRL secretion at 4 h after its administration. This effect was already significant at 2 h and lasted till 8 h. Metergoline, a 5‐HT receptor blocker, when administered alone, decreased serum PRL levels in six healthy subjects. The pretreatment with this drug significantly antagonized the PRL‐releasing action of fenfluramine (60 mg) suggesting that the effect of fenfluramine on PRL release may be mediated through a 5‐HT mechanism in the brain. These findings suggest the possibility that serum PRL levels in humans may represent a useful tool to evaluate, in vivo, the activity of drugs possessing putative 5‐ hydroxytryptaminergic properties. 1983 The British Pharmacological Society

Original languageEnglish
Pages (from-to)471-475
Number of pages5
JournalBritish Journal of Clinical Pharmacology
Volume16
Issue number5
DOIs
Publication statusPublished - 1983

Fingerprint

Fenfluramine
Prolactin
Neurons
Pharmaceutical Preparations
Healthy Volunteers
Metergoline
Serum
Oral Administration
Brain

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Prolactin secretion in man : a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine. / Quattrone, A.; Tedeschi, G.; Aguglia, U.; Scopacasa, F.; Direnzo, GF; Annunziato, L.

In: British Journal of Clinical Pharmacology, Vol. 16, No. 5, 1983, p. 471-475.

Research output: Contribution to journalArticle

@article{d9c9b0be3e2d43f0bb103392db9e8e86,
title = "Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.",
abstract = "Acute oral administration of various doses of fenfluramine, a 5‐HT releaser, induced a dose‐related increase of PRL secretion in nine healthy volunteers. Fenfluramine reached the maximum effect on PRL secretion at 4 h after its administration. This effect was already significant at 2 h and lasted till 8 h. Metergoline, a 5‐HT receptor blocker, when administered alone, decreased serum PRL levels in six healthy subjects. The pretreatment with this drug significantly antagonized the PRL‐releasing action of fenfluramine (60 mg) suggesting that the effect of fenfluramine on PRL release may be mediated through a 5‐HT mechanism in the brain. These findings suggest the possibility that serum PRL levels in humans may represent a useful tool to evaluate, in vivo, the activity of drugs possessing putative 5‐ hydroxytryptaminergic properties. 1983 The British Pharmacological Society",
author = "A. Quattrone and G. Tedeschi and U. Aguglia and F. Scopacasa and GF Direnzo and L. Annunziato",
year = "1983",
doi = "10.1111/j.1365-2125.1983.tb02202.x",
language = "English",
volume = "16",
pages = "471--475",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Prolactin secretion in man

T2 - a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.

AU - Quattrone, A.

AU - Tedeschi, G.

AU - Aguglia, U.

AU - Scopacasa, F.

AU - Direnzo, GF

AU - Annunziato, L.

PY - 1983

Y1 - 1983

N2 - Acute oral administration of various doses of fenfluramine, a 5‐HT releaser, induced a dose‐related increase of PRL secretion in nine healthy volunteers. Fenfluramine reached the maximum effect on PRL secretion at 4 h after its administration. This effect was already significant at 2 h and lasted till 8 h. Metergoline, a 5‐HT receptor blocker, when administered alone, decreased serum PRL levels in six healthy subjects. The pretreatment with this drug significantly antagonized the PRL‐releasing action of fenfluramine (60 mg) suggesting that the effect of fenfluramine on PRL release may be mediated through a 5‐HT mechanism in the brain. These findings suggest the possibility that serum PRL levels in humans may represent a useful tool to evaluate, in vivo, the activity of drugs possessing putative 5‐ hydroxytryptaminergic properties. 1983 The British Pharmacological Society

AB - Acute oral administration of various doses of fenfluramine, a 5‐HT releaser, induced a dose‐related increase of PRL secretion in nine healthy volunteers. Fenfluramine reached the maximum effect on PRL secretion at 4 h after its administration. This effect was already significant at 2 h and lasted till 8 h. Metergoline, a 5‐HT receptor blocker, when administered alone, decreased serum PRL levels in six healthy subjects. The pretreatment with this drug significantly antagonized the PRL‐releasing action of fenfluramine (60 mg) suggesting that the effect of fenfluramine on PRL release may be mediated through a 5‐HT mechanism in the brain. These findings suggest the possibility that serum PRL levels in humans may represent a useful tool to evaluate, in vivo, the activity of drugs possessing putative 5‐ hydroxytryptaminergic properties. 1983 The British Pharmacological Society

UR - http://www.scopus.com/inward/record.url?scp=0021029381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021029381&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.1983.tb02202.x

DO - 10.1111/j.1365-2125.1983.tb02202.x

M3 - Article

C2 - 6639832

AN - SCOPUS:0021029381

VL - 16

SP - 471

EP - 475

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 5

ER -